SecBot SecBot
8-K ·Filed May 27, 2026

TFX

TELEFLEX INC
NEUTRAL
Impact 4/10
Horizonweeks Processed5mo ago SEC0001193125-26-242184
8-K material event: Items 1.01
Actionable Insight • Neutral

This is a routine refinancing that extends maturity profiles and likely improves pricing terms versus the prior facility. The transaction does not change Teleflex's total debt or equity. Monitor upcoming quarterly filings for the impact of the pending Acute Care and OEM divestitures (announced Dec 2025) on leverage and the new covenant headroom.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$128.90
T+0 close · May 27, 2026 · via day close
Latest settled
+7.14%
T+60 · $138.11
Vs SPY
+5.67%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 28 $128.90entry
  2. T+1 · 6mo ago −0.28%α −0.52% · $128.54
  3. T+5 · 6mo ago +1.66%α +1.34% · $131.04
  4. T+20 · 5mo ago −0.86%α +1.83% · $127.79
  5. T+60 · 3mo ago +7.14%α +5.67% · $138.11

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Teleflex refinanced its existing credit facility by entering into a new $2.2 billion Credit Agreement on May 26, 2026. The new facility includes a $1.0 billion five-year revolving credit facility (maturing May 2031), a $500 million term A-1 loan (maturing May 2031), and a $700 million term A-2 loan (maturing May 2028). The agreement refinances the prior November 2022 credit agreement and contains financial covenants requiring a maximum total net leverage ratio of 4.50x and a minimum interest coverage ratio of 3.00x, with customary terms for a large, investment-grade credit profile medical device company.

Key Financial Metrics

Deal Type
credit_facility

Key Facts

  • Total new credit commitments of $2.2 billion: $1.0B revolver, $500M Term A-1, $700M Term A-2
  • Revolver and Term A-1 mature May 26, 2031 (5-year); Term A-2 matures May 26, 2028
  • Interest rates: Term SOFR + 1.125%-2.00% or ABR + 0.125%-1.00% based on leverage/ratings
  • Financial covenants: max total net leverage ratio 4.50x; min interest coverage ratio 3.00x
  • Refinances the prior Third Amended and Restated Credit Agreement dated Nov 4, 2022
  • Secured by substantially all domestic material subsidiary assets and pledges of equity

Financial Impact

Refinancing of $2.2 billion in credit facilities. Proceeds used to repay existing indebtedness. No new incremental borrowing or change in total debt size disclosed.

leverageliquiditydebt_maturity_profile

Risk Factors

  • Pending divestitures of Acute Care and OEM businesses could temporarily increase leverage post-closing
  • Future use of the $700M Term A-2 (maturing 2028) creates a refinancing risk in ~2 years

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
29% bullish (17 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-242184
Document: d126197d8k.htm0001193125-26-242184
Document: 0001193125-26-242184-index-headers.html0001193125-26-242184
Document: 0001193125-26-242184-index.html0001193125-26-242184
Document: 0001193125-26-242184.txt0001193125-26-242184

Track record

11 reports on TFX

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $154.69 Now $155.10 +0.27% settles Nov 23
  2. Nov 5, 202611d ago 8-K Bullish 6/10 Entry $152.15 to $153.15 Now $155.10 +1.94% ▲ +0.66% −2.63% vs SPY
  3. Aug 6, 202614w ago 8-K Mixed 6/10 Entry $138.89 to $137.37 Now $155.10 +11.67% ▼ −1.09% −2.31% vs SPY
  4. Jul 2, 202619w ago Court Ruling Bullish 6/10 Entry $133.99 to $134.04 Now $155.10 +15.75% ▲ +0.04% −0.89% vs SPY
  5. Jun 22, 202621w ago Institutional Cluster Mixed 4/10 Entry $121.67 to $129.86 Now $155.10 +27.48% ▲ +6.73% +8.80% vs SPY
  6. Jun 15, 202622w ago 8-K Neutral 4/10 Entry $127.87 to $124.26 Now $155.10 +21.30% ▼ −2.82% −0.59% vs SPY
  7. Jun 9, 202622w ago 8-K Neutral 2/10 Entry $132.15 to $127.87 Now $155.10 +17.37% ▼ −3.24% −6.67% vs SPY
  8. Jun 1, 202624w ago 8-K Neutral 4/10 Entry $127.31 to $129.84 Now $155.10 +21.82% ▲ +1.98% +4.73% vs SPY
  9. May 27, 202624w ago 8-K Neutral 4/10 Viewing Entry $128.90 to $131.04 Now $155.10 +20.32% ▲ +1.66% +1.34% vs SPY
  10. May 7, 202627w ago 8-K Mixed 6/10 Entry $131.59 to $130.04 Now $155.10 +17.86% ▼ −1.18% −2.69% vs SPY
Showing 10 of 11

US Market Status

Market Closed · Opens Wed (12h 41m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 27, 2026